On Monday shares of Immunomedics Inc. (NASDAQ:IMMU) closed at $4.22. Company’s sales growth for last 5 years was -21.40%. Immunomedics, Inc. (NASDAQ:IMMU) announced that the FDA has granted fast track designation to its lead antibody-drug conjugate program sacituzumab govitecan for the treatment of patients suffering from metastatic non-small cell lung cancer (NSCLC) who have failed two prior lines of therapy.
ChannelAdvisor Corporation (NYSE:ECOM) in last trading activity increased 5.05% to close at $11.45. Company weekly performance is 4.57% while its quarterly performance stands at 20.78%. ChannelAdvisor Corporation (NYSE:ECOM) is -57.84% away from its 52 week high. ChannelAdvisor Corporation (NYSE: ECOM) on 5 May, announced that its Board of Directors has appointed David Spitz as Chief Executive Officer (CEO) and a Director, effective today. Spitz, who currently serves as President and Chief Operating Officer, succeeds Scot Wingo, who has been appointed Executive Chairman.
On last trading day E*TRADE Financial Corporation (NASDAQ:ETFC) increased 2.86% to close at $29.84. Its volatility for the week is 2.41% while volatility for the month is 2.46%. ETFC’s sales growth for past 5 years was -7.10% and its EPS growth for past 5 years was 15.80%. E*TRADE Financial Corporation (NASDAQ:ETFC) monthly performance is 8.27%. Zacks lowered shares of E*TRADE Financial Corp (NASDAQ:ETFC) from a buy rating to a hold rating in a report released on Wednesday.
ImmuCell Corp. (NASDAQ:ICCC) has 8.60% insider ownership while its institutional ownership stands at 8.40%. In last trading activity company’s stock closed at $8.03. ImmuCell Corp. (NASDAQ:ICCC) reported first quarter EPS of $0.15 after the close on 12 May, compared to the loss of $0.00 in the prior year period. ImmuCell gapped up Wednesday morning and has risen sharply in early trade on the highest volume of the year. The stock is now up 2.12 at $7.77 and has soared to a new high for the year.
On last trading day Invacare Corporation (NYSE:IVC) increased 0.60% to close at $21.75. Its volatility for the week is 3.47% while volatility for the month is 3.13%. IVC’s sales growth for past 5 years was -5.60% and its EPS growth for past 5 years was -29.70%. Invacare Corporation (NYSE:IVC) monthly performance is 11.25%. On 15 May, Invacare Corporation (NYSE:IVC) CEO Matthew E. Monaghan has been further cemented in the medical products company’s corporate governance structure. Elyria-based Invacare (NYSE: IVC) said its shareholders have elected to the board of directors Monaghan and Clifford D. Nastas, a director of the Dan T. Moore Co. and president of a group of its automotive and advanced materials operating companies.